Flputnam Investment Management Co. Acquires Shares of 691,989 AirSculpt Technologies, Inc. $AIRS

Flputnam Investment Management Co. acquired a new position in shares of AirSculpt Technologies, Inc. (NASDAQ:AIRS) during the 2nd quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm acquired 691,989 shares of the company’s stock, valued at approximately $3,114,000. Flputnam Investment Management Co. owned about 0.96% of AirSculpt Technologies as of its most recent filing with the Securities & Exchange Commission.

A number of other hedge funds and other institutional investors have also made changes to their positions in the company. Larson Financial Group LLC lifted its holdings in shares of AirSculpt Technologies by 20.4% in the 3rd quarter. Larson Financial Group LLC now owns 15,137 shares of the company’s stock valued at $121,000 after purchasing an additional 2,561 shares during the last quarter. Wexford Capital LP grew its stake in AirSculpt Technologies by 2.6% during the 3rd quarter. Wexford Capital LP now owns 102,614 shares of the company’s stock worth $823,000 after buying an additional 2,614 shares during the last quarter. Rhumbline Advisers increased its position in AirSculpt Technologies by 16.1% during the third quarter. Rhumbline Advisers now owns 20,782 shares of the company’s stock worth $167,000 after buying an additional 2,876 shares during the period. Creative Planning lifted its stake in AirSculpt Technologies by 32.2% in the second quarter. Creative Planning now owns 13,225 shares of the company’s stock valued at $64,000 after buying an additional 3,224 shares during the last quarter. Finally, BNP Paribas Financial Markets lifted its stake in AirSculpt Technologies by 239.5% in the third quarter. BNP Paribas Financial Markets now owns 5,952 shares of the company’s stock valued at $48,000 after buying an additional 4,199 shares during the last quarter. Institutional investors and hedge funds own 91.54% of the company’s stock.

AirSculpt Technologies Price Performance

AirSculpt Technologies stock opened at $2.60 on Monday. AirSculpt Technologies, Inc. has a 12 month low of $1.51 and a 12 month high of $12.00. The company has a debt-to-equity ratio of 0.32, a current ratio of 0.79 and a quick ratio of 0.79. The business has a 50 day simple moving average of $4.06 and a 200-day simple moving average of $3.58. The stock has a market capitalization of $187.45 million, a PE ratio of -14.44 and a beta of 2.33.

AirSculpt Technologies (NASDAQ:AIRS) last posted its quarterly earnings data on Monday, August 10th. The company reported $0.01 earnings per share for the quarter, missing analysts’ consensus estimates of $0.02 by ($0.01). The firm had revenue of $42.90 million during the quarter, compared to analysts’ expectations of $44.14 million. AirSculpt Technologies had a negative net margin of 7.79% and a negative return on equity of 5.83%.

Wall Street Analyst Weigh In

A number of equities analysts have recently issued reports on the stock. Wall Street Zen lowered shares of AirSculpt Technologies from a “buy” rating to a “hold” rating in a research report on Saturday, August 15th. Leerink Partners set a $4.50 price target on shares of AirSculpt Technologies in a research report on Thursday, May 14th. Finally, Weiss Ratings raised shares of AirSculpt Technologies from a “sell (e+)” rating to a “sell (d-)” rating in a research report on Wednesday, July 1st. One analyst has rated the stock with a Hold rating and one has assigned a Sell rating to the stock. According to MarketBeat, the stock presently has a consensus rating of “Reduce” and a consensus target price of $4.50.

About AirSculpt Technologies

AirSculpt Technologies, Inc (NASDAQ: AIRS) is a medical technology company specializing in minimally invasive body contouring. The company’s flagship AirSculpt® platform combines pneumatic power with precision microcannulas to deliver fat removal, transfer and sculpting procedures. AirSculpt Technologies partners with both company-owned and franchised cosmetic surgery practices to offer a streamlined, office-based alternative to traditional liposuction.

Through its proprietary system, AirSculpt Technologies provides both consumers and medical professionals with an integrated solution that emphasizes reduced downtime, smaller incision sites, and more predictable outcomes.